Roche wins FDA nod for HER2 companion diagnostics in GEA
Roche (SIX: RO, ROG; OTCQX: RHHBY) has received FDA approval to expand the use of two companion diagnostic tests to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
